Vaxcyte Inc (NASDAQ: PCVX) open the trading on Thursday, with a bit cautious approach as it glided -3.22% to $90.04, before settling in for the price of $93.04 at the close. Taking a more long-term approach, PCVX posted a 52-week range of $53.26-$121.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -46.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.15%. This publicly-traded company’s shares outstanding now amounts to $124.43 million, simultaneously with a float of $120.20 million. The organization now has a market capitalization sitting at $11.22 billion. At the time of writing, stock’s 50-day Moving Average stood at $104.20, while the 200-day Moving Average is $83.91.
Vaxcyte Inc (PCVX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Vaxcyte Inc’s current insider ownership accounts for 3.56%, in contrast to 107.36% institutional ownership. Preceding that transaction, on Dec 02 ’24, Company’s CHIEF EXECUTIVE OFFICER sold 15,000 for 92.45, making the whole transaction’s value amount to 1,386,794. This particular insider is now the holder of 450,301 in total.
Vaxcyte Inc (PCVX) Earnings and Revenue Records
Vaxcyte Inc’s EPS increase for this current 12-month fiscal period is 5.15% and is forecasted to reach -4.69 in the upcoming year.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Let’s observe the current performance indicators for Vaxcyte Inc (PCVX). It’s Quick Ratio in the last reported quarter now stands at 17.88. The Stock has managed to achieve an average true range (ATR) of 4.07.
In the same vein, PCVX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.68, a figure that is expected to reach -1.12 in the next quarter, and analysts are predicting that it will be -4.69 at the market close of one year from today.
Technical Analysis of Vaxcyte Inc (PCVX)
[Vaxcyte Inc, PCVX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 55.59% While, its Average True Range was 3.91.
Raw Stochastic average of Vaxcyte Inc (PCVX) in the period of the previous 100 days is set at 38.71%, which indicates a major fall in contrast to 53.91% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 42.77% that was lower than 61.07% volatility it exhibited in the past 100-days period.
